By Benjamin Chiou
Date: Friday 06 Nov 2026
(Sharecast News) - Moderna shares rose in early trading on Friday after the US biotechnology company raised its full-year revenue forecast following stronger-than-expected third-quarter sales and a return to profit.
The company now expects revenue growth of 15% to 25% in 2026, up from previous guidance of up to 10%, driven...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news